AME
65
-6
BF.B
59
-2
CA
21
-6
C
79
-2
ALLE
46
-7
AZO
43
-2
EOG
49
-3
ETR
52
-2
DHR
66
-4
CVS
39
-11
CL
59
3
EQT
50
-4
CSCO
60
-4
EMN
62
-3
COF
65
-3
CHD
37
2
AEP
59
-2
BMY
74
5
AIZ
59
-2
ED
39
3
AME
65
-6
BF.B
59
-2
CA
21
-6
C
79
-2
ALLE
46
-7
AZO
43
-2
EOG
49
-3
ETR
52
-2
DHR
66
-4
CVS
39
-11
CL
59
3
EQT
50
-4
CSCO
60
-4
EMN
62
-3
COF
65
-3
CHD
37
2
AEP
59
-2
BMY
74
5
AIZ
59
-2
ED
39
3
Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$25.23
Seasonality Move:
7.92%
Buy
77

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.50
Seasonality Move:
-9.01%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.23. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $25.23
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.69 Buy
Relative Strength Index (14 RSI): 68.46 Buy
Chaikin Money Flow: 1409326 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.36 - 23.18) Buy
Bollinger Bands (100): (20.82 - 26.96) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.69 Buy
20-day SMA: 21.71 Buy
50-day SMA: 23.11 Buy
200-day SMA: 21.92 Buy
8-day EMA: 23.84 Buy
20-day EMA: 22.66 Buy
50-day EMA: 22.73 Buy
200-day EMA: 24.25 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):